Complete Genomics Inc (GNOM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GNOM Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Complete Genomics Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2012)
(Jun 30 2012) (Mar 31 2012) (Dec 31 2011) (Sep 30 2011)
Assets
Cash & cash equivalent34.72
Short-term Investments, Total0.00
Cash & Short-term Investments34.00
Accounts receivable5.39
Inventories6.76
Other Current Assets0.09
Prepaid Expense, Current AS1.33
Total Current Assets48.30
Equipment/Property/Plant Net31.39
Other Assets, Noncurrent1.00
Total Assets80.82
Liabilities
Accounts Payable, Current AC4.97
Accrued Liabilities, Current AC5.98
Notes Payable, Current NO19.44
Other Liabilities, Current6.00
Deferred Revenue, Current DE9.09
Total Current Liabilities45.48
Long-term debt0.00
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE2.90
Other liabilities, Noncurrent0.00
Total Liabilities48.38
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock300.65
Retained Earnings / Accumulated Deficit-268.24
Other Equity0.00
Common Stockholder's Equity32.44
Total Stockholder's Equity32.44
Liabilities & Stockholder's Equity80.82
4 historic quarters locked

Sign in to unlock the full Complete Genomics Inc balance sheet history.

About GNOM Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.